These include for example the tuberous sclerosis complex-1 (TSC1) gene, which in recent years has been associated with TAU pathology in frontotemporal dementia and Alzheimer's disease, where loss-of-function TSC1 inclusions lead to an increase of TAU burden [234–236]. The gene discussed is TSC1; the disease is frontotemporal dementia.